Jupiter Life LinQ2 FY25

Jupiter Life Lin Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹289.75P/E: 50.0Market Cap: ₹9.5K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2
  • Indore hospital is expanding by about 75-80 beds expected to start operations next quarter, contributing to revenue growth.
  • Pune hospital added 22 beds recently, with scope to add 10-12 more beds, nearing full capacity.
  • Indore's large land area (+5 acres) allows for expansion up to 200 beds depending on demand.
  • New Greenfield projects in Dombivli (500 beds, operation expected by CY 2026) and Pune (awaiting regulatory approval; construction to start post Q4 FY25) will drive future growth.
  • Bed occupancy at Indore increased from 57% in H1 FY25 to 61% in Q2 FY25, indicating rising utilization.
  • After capacity expansion, revenue volumes are expected to grow in absolute terms despite temporary percentage dips due to increased bed base.
  • EBITDA and PAT growth seen with aspirations to maintain EBITDA margin around 25%.

See what Jupiter Life Lin management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no specific mention of any current or planned fundraising through debt or equity in the provided transcript.
  • The management discusses ongoing and upcoming CAPEX, particularly for Dombivli (around Rs. 150 crore) and Pune (Rs. 50+ crore) for FY26, but does not specify the funding source.
  • They mention being mindful of "value we need to pay" for growth opportunities, implying caution on acquisitions or expansions.
  • The focus seems to be on organic growth through existing and planned projects, with no explicit indication of immediate fundraising needs via debt or equity.
  • For any off-announced or new projects beyond current plans, funding details are not disclosed in this call.

See what Jupiter Life Lin management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Current and near-future CAPEX primarily focused on two Greenfield projects:
  • - Dombivli: Construction underway for a 500-bed hospital; expected operations start in calendar year 2026.
  • - Pune: Regulatory approval expected in Q4 FY25 with construction to begin soon after.
  • CAPEX estimates for FY26:
  • - Dombivli requires approximately Rs. 150 crore.
  • - Pune requires an additional Rs. 50+ crore.
  • Existing facilities at Thane, Pune, and Indore are largely set in terms of CAPEX requirements for now.
  • Expansion within existing hospitals includes adding 75-80 new beds in Indore, and 10-12 more beds possible in Pune.
  • No announced plans currently for inorganic growth or acquisitions, but management is open to opportunities if value aligns.

Track Jupiter Life Lin — get its next earnings analysis in your feed

How does Jupiter Life Lin rank vs peers in Healthcare Services?

Pro feature
ThisJupiter Life Lin
Rev 2Mar 3

How does Jupiter Life Lin rank in Healthcare Services?

Compare Jupiter Life Lin against every Healthcare Services company (Q2 FY25) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →